Categories
China Intelwars new pandemic New swine fu pandemic Researchers SWINE FLU

New swine flu with ‘pandemic potential’ discovered in China once more

Researchers in China have discovered a brand-new type of swine flu that is able to infect humans.

What are the details?

A new study, released Monday and published in the scientific journal Proceedings of the National Academy of Sciences, found that the new mutation may be capable of causing a new pandemic. Researchers, however, say that the virus does not pose an immediate risk to global health.

The virus, referred to as the G4 virus, is a strain of H1N1 swine flu, and exhibits “all the essential hallmarks of a candidate pandemic virus.”

Researchers gained the information after studying pigs from 2011 to 2018. Scientists obtained nasal swab samples from more than 30,000 slaughterhouse pigs and veterinary teaching hospitals across 10 China provinces.

The samples rendered at least 179 different swine flu viruses.

Researchers said that seasonal influenza vaccines will not provide patients with immunity against the new strain.

Agence France-Presse reported Tuesday:

According to blood tests which showed up antibodies created by exposure to the virus, 10.4 percent of swine workers had already been infected.

The tests showed that as many as 4.4 percent of the general population also appeared to have been exposed.

The virus has therefore already passed from animals to humans but there is no evidence yet that it can be passed from human to human — the scientists’ main worry.

What are people saying about this?

CNN cites remarks from Dr. Angela Rasmussen, a virologist at Columbia University’s school of public health.

“[T]he bottom line is that our understanding of what is a potential pandemic influenza strain is limited,” she wrote in a tweet. “Sure, this virus meets a lot of the basic criteria but it’s not for sure going to cause a hypothetical 2020 flu pandemic, or even be a dominant strain in humans.”

Carl Bergstrom, a biology professor at the University of Washington, tweeted, “There’s no evidence that G4 is circulating in humans, despite five years of extensive exposure. That’s the key context to keep in mind.”

Share
Categories
Americans Coronavirus COVID-19 cure Department of Defense Dr. anthony fauci effective Fear Headline News injection devices Intelwars Jake Tapper LIES Los Angeles New York City pandemic Researchers United States vaccinate everyone vaccines

$138 Million Government Contract Will Fund Production Of 500 Million Pre-Filled COVID-19 Vaccine “Injection Devices”

This article was originally published by Michael Snyder at The End of the American Dream. 

Just when you thought that things couldn’t get any stranger, two U.S. government agencies have taken things to an entirely new level.  The U.S. Department of Defense and the U.S. Department of Health and Human Services have just put out a press release that is absolutely jaw-dropping, but so far hardly anyone is talking about it.

According to the press release, a 138 million dollar contract has been awarded to ApiJect Systems America for two projects known as “Project Jumpstart” and “RAPID USA”.  Apparently the goal of these projects is to have vast numbers of “injection devices” ready to go once a COVID-19 vaccine becomes available.  The following comes directly from the official website of the Department of Defense

“Today the Department of Defense and the U.S. Department of Health and Human Services, announce a $138 million contract with ApiJect Systems America for “Project Jumpstart” and “RAPID USA,” which together will dramatically expand U.S. production capability for domestically manufactured, medical-grade injection devices starting by October 2020.

Spearheaded by the DOD’s Joint Acquisition Task Force (JATF), in coordination with the HHS Office of the Assistant Secretary for Preparedness and Response, the contract will support “Jumpstart” to create a U.S.-based, high-speed supply chain for prefilled syringes beginning later this year by using well-established Blow-Fill-Seal (BFS) aseptic plastics manufacturing technology, suitable for combatting COVID-19 when a safe and proven vaccine becomes available.

Today, there are about 328 million people living in the United States.  But the press release states that the plan is to produce “over 500 million prefilled syringes” in 2021

The contract also enables ApiJect Systems America to accelerate the launch of RAPID USA manufactured in new and permanent U.S.-based BFS facilities with the ultimate production goal of over 500 million prefilled syringes (doses) in 2021. This effort will be executed initially in Connecticut, South Carolina and Illinois, with potential expansion to other U.S.-based locations. RAPID will provide increased lifesaving capability against future national health emergencies that require population-scale vaccine administration on an urgent basis.

So that would be enough “injection devices” to vaccinate every man, woman, and child in the entire country one and a half times.

Wow.

Right now, researchers all over the globe are racing toward the development of a vaccine, but as I have discussed previously, that is not going to be an easy task.

And on Tuesday Dr. Anthony Fauci openly admitted to a U.S. Senate committee that there is no guarantee that a vaccine “is actually going to be effective”

As drugmakers across the world race to develop a coronavirus vaccine, White House health advisor Dr. Anthony Fauci said, “There’s no guarantee that the vaccine is actually going to be effective.”

Fauci delivered the somber warning Tuesday to the Senate Committee on Health, Education, Labor and Pensions during a hearing about the road to reopening businesses across the nation.

In addition, because there are multiple strains of COVID-19 already running around out there, one vaccine may not be able to cover them all.  So this could create a need for “multiple vaccines”, and this is something that NIH Director Francis Collins has openly acknowledged

Several vaccines will likely be needed to combat the coronavirus and immunize groups of people in America and abroad, U.S. National Institutes of Health Director Francis Collins said in an interview.

So when the time finally comes, there may be more than one vaccine that authorities are pushing everyone to take.

But for now, there is no vaccine, and some health officials are pushing for social distancing restrictions to remain in place for months to come.

For example, Fox News is reporting that the top health official of Los Angeles County is warning that the local “stay-at-home order” may have to be extended until August…

Los Angeles County will likely continue its stay-at-home order through the summer, officials said Tuesday, as the coronavirus wreaks havoc on the economy and patience continues to wear thin for some calling for the state to reopen and for normal life to resume.

County Public Health Director Barabara Ferrer said the order will be extended “with all certainty” at the Board of Supervisors meeting, possibly until July or August, the Los Angeles Times reported.

And apparently L.A. Mayor Eric Garcetti is on the same page.  In fact, he has once again stated that there will be no return to normal until a cure or a vaccine comes along

“I think quite simply she’s saying we’re not going to fully reopen Los Angeles — or anywhere in America — without any protections or health orders in the next three months,” he told CNN’s Jake Tapper.

“I think we know it’s going to be even longer than three months. … We’re not moving past Covid-19, we’re learning to live with it. We’re not going to go back to pre-Covid life any time soon” or move forward without a medicine or vaccine.

I feel so badly for those living in the Los Angeles area because it certainly looks like the next three months are going to be really rough.

Of course, there are other large cities that are facing similar timelines.  Just check out what is being reported regarding the outlook for New York City…

New York City may not fully reopen until August after Gov. Cuomo advised that each phase of the four phase restart plan could take up to two weeks to implement.

Parts of the state of New York will be ready to reopen on May 15, this Friday, after meeting Governor Cuomo’s strict set of seven requirements.

We are only in mid-May right now.

Could you imagine being forced to stay home for the next three months?

Sadly, that is what millions of Americans will be facing.

And on Tuesday Dr. Fauci actually suggested that many schools will need to remain closed as the next school year begins

Anthony Fauci, MD, revealed Tuesday morning that a return to school in the fall “would be a bit of a bridge too far,” during a Senate Committee hearing. News of likely continued homeschooling for the next school year will probably be met with groans and frustration by harried parents struggling to balance working from home and also managing remote learning and having their children home 100 percent of the time.

Our entire society is melting down because of this virus, and if we can’t handle this crisis, what are we going to do when much worse things start happening to us?

Sometimes I wish that we could roll back the clock and go back to 2019.

Life seemed so much simpler back then, and things are only going to get crazier in the weeks and months to come…

About the Author: I am a voice crying out for change in a society that generally seems content to stay asleep. My name is Michael Snyder and I am the publisher of The Economic Collapse BlogEnd Of The American Dream, and The Most Important News, and the articles that I publish on those sites are republished on dozens of other prominent websites all over the globe. I have written four books that are available on Amazon.com including The Beginning Of The EndGet Prepared Now, and Living A Life That Really Matters. (#CommissionsEarned) By purchasing those books you help to support my work. I always freely and happily allow others to republish my articles on their own websites, but due to government regulations, I need those that republish my articles to include this “About the Author” section with each article. In order to comply with those government regulations, I need to tell you that the controversial opinions in this article are mine alone and do not necessarily reflect the views of the websites where my work is republished. The material contained in this article is for general information purposes only, and readers should consult licensed professionals before making any legal, business, financial, or health decisions. Those responding to this article by making comments are solely responsible for their viewpoints, and those viewpoints do not necessarily represent the viewpoints of Michael Snyder or the operators of the websites where my work is republished. I encourage you to follow me on social media on Facebook and Twitter, and anyway that you can share these articles with others is a great help.  During these very challenging times, people will need hope more than ever before, and it is our goal to share the gospel of Jesus Christ with all many people as we possibly can.

Share
Categories
BATS China Chinese lab Coronavirus Coronavirus america Coronavirus outbreak Intelwars lab National Review pandemic Researchers Tucker Carlson WHO World health oranization Wuhan Institute of Virology Wuhan lab Wuhat wet market

New evidence suggesting COVID-19 came from a Wuhan virology lab is hard to ignore

Several new pieces of publicly available evidence that have come to light in recent days seem to indicate that a virology lab in Wuhan, China, may have been the location where the novel coronavirus originated.

In a lengthy article published Friday, National Review senior correspondent Jim Geraghty detailed the investigatory work of Matthew Tye, a documentary filmmaker and YouTuber who used to live in China. In his most recent video upload, Tye professes to have identified the source of the virus.

Geraghty is sure to note that it “is understandable that many would be wary of the notion that the origin of the coronavirus could be discovered” by a YouTuber, but contends “a great deal of the information that he presents, obtained from public records posted on the Internet, checks out.”

Two examples of this are all-too-coincidental job openings posted late last year by the Wuhan Institute of Virology — the lab located just 300 meters from the Huanan Seafood Wholesale Market that has been frequently cited as the source location for the coronavirus.

Suspicious job postings

On Nov. 18, the lab posted a job opening that requested scientists to come “research the relationship between the coronavirus and bats.”

According to a Google translation of the job posting, it offers this description of the nature of the work:

Taking bats as the research object, I will answer the molecular mechanism that can coexist with Ebola and SARS- associated coronavirus for a long time without disease, and its relationship with flight and longevity. Virology, immunology, cell biology, and multiple omics are used to compare the differences between humans and other mammals.

Then, just over a month later on Dec. 24, the lab posted another job opening, this time noting “long-term research on the pathogenic biology of bats carrying important viruses has confirmed the origin of bats of major new human and livestock infectious diseases such as SARS and SADS, and a large number of new bat and rodent new viruses have been discovered and identified.”

Tye, who claims to speak fluent Chinese, said that the second job posting could be essentially translated: “We’ve discovered a new and terrible virus, and would like to recruit people to come deal with it.”

At the time of the second job posting, China had reportedly been dealing with an onslaught of “mystery pneumonia” cases, but it wasn’t until a week later that the Chinese government notified the World Health Organization about a novel coronavirus infecting its population.

Then, a scientific research paper

Fox News host Tucker Carlson ran an interesting segment on his primetime show Tuesday night highlighting a research paper published on Feb. 6 by the South China University of of Technology.

The research paper — “The possible origins of 2019-nCoV coronavirus” — noted that virus most likely came from an animal known as the intermediate horseshoe bat.

“Here’s the striking thing,” Carlson said, “there are no known colonies [of the bat] within 900 kilometers of Wuhan.”

Moreover, Carlson noted that there is no evidence to support the oft-repeated claims that this particular bat was sold at the wet markets in Wuhan. The Wall Street Journal reported in February that neither the U.S. Centers for Disease Control and Prevention nor the World Health Organization could confirm whether bats were present in the market.

Watch the full segment here:


Tucker Carlson Blasting WHO Shilling For China & Possible Origin Of Coronavirus in Wuhan Labs

youtu.be

What does it mean?

The evidence appears to demonstrate that Chinese scientists at the Wuhan Institute of Virology were researching coronaviruses in bats (allegedly not typically found within 900 kilometers of the city) at the same time that doctors began treating the first known COVID-19 patients.

It is difficult not to draw certain conclusions from that, but to be clear, it is impossible to conclude with 100% certainty that the virus originated in a virology lab in Wuhan.

And even if it were, it is important to note that neither Geraghty nor Carlson, nor the cited Chinese research paper for that matter, are suggesting that the virus was made intentionally in a Chinese lab as part of a biological weapon program.

The matter at hand is more so about the misinformation coming from the communist government in China following the outbreak.

Share
Categories
Coronavirus Coronavirus america Coronavirus outbreak Coronavirus us Coronavirus vaccine COVID-19 Covid-19 vaccine Intelwars patch Pittsburgh Pittsburgh vaccine Researchers Spike protein University of Pittsburgh Vaccine

University of Pittsburgh researchers say they have developed a potential COVID-19 vaccine

Researchers at the University of Pittsburgh School of Medicine believe they have developed a potential vaccine for COVID-19.

The researchers announced the news in a study published in EBioMedicine Thursday, calling the potential vaccine a “promising immunization strategy” and noting that it could be introduced and distributed quickly enough to “significantly impact the spread of disease.”

The vaccine, called PittCoVacc, is made of dissolvable sugar and bits of a particular protein known as the spike protein, which the virus uses to attach to cells and infect its host. When tested in mice, it was found to produce what is thought to be the sufficient number of antibodies needed to counteract the virus.

The researchers said they were able to move so quickly because of their past work developing potential vaccines for similar coronaviruses such as Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS).

“We had previous experience on SARS-CoV in 2003 and MERS-CoV in 2014. These two viruses, which are closely related to SARS-CoV-2, teach us that a particular protein, called a spike protein, is important for inducing immunity against the virus,” said co-senior author Andrea Gambotto, M.D., associate professor of surgery at the Pitt School of Medicine.

“We knew exactly where to fight this new virus,” he added.

The possible vaccine was developed the old-fashioned way “using lab-made pieces of viral protein to build immunity,” according to a news release from the school — the same way current flu shots work. But it is delivered in a novel way, using a small fingertip-sized patch, similar to a BandAid. The patch goes on and then 400 tiny needles deliver the vaccine into the skin, where the immune reaction is the strongest.

“It’s actually pretty painless — it feels kind of like Velcro,” co-senior author Louis Falo, M.D., Ph.D., professor and chair of dermatology at Pitt’s School of Medicine and UPMC, said.

The researchers are now seeking approval from the U.S. Food and Drug Administration in order to advance to testing in humans, and they hope that the FDA will fast-track the normally lengthy process.

“Testing in patients would typically require at least a year and probably longer,” Falo said. “This particular situation is different from anything we’ve ever seen, so we don’t know how long the clinical development process will take. Recently announced revisions to the normal processes suggest we may be able to advance this faster.”


Pitt Unveils Possible Coronavirus Vaccine

youtu.be

Share